Ciprian Tomuleasa

Papers

1

Total Citations

10

H-Index

1

About

Dr. Ciprian Tomuleasa is a leading figure in translational oncology and perioperative medicine, whose work bridges the critical gap between surgical outcomes and biomarker-driven patient care. His research focuses on the molecular mechanisms of cancer progression and the optimization of anesthetic management to reduce organ injury in surgical oncology. A key contribution is his investigation into how different anesthetic techniques influence renal stress, as demonstrated in his highly cited study on neutrophil gelatinase-associated lipocalin (NGAL) levels after robotic urogenital oncosurgery. This work, which has garnered over 10 citations, established a vital link between anesthetic choice and early detection of acute kidney injury, offering a pathway to safer, more personalized perioperative care. Beyond this, Dr. Tomuleasa has made significant strides in understanding cancer stem cell biology and developing novel therapeutic strategies for hematologic malignancies. His impact is reflected in a growing body of work that not only advances fundamental science but also directly informs clinical protocols, making him a pivotal voice in the quest to improve survival and quality of life for cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology.
10 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago